
12-Crown-4 | CAS:294-93-9
12-Crown-4
- Name:12-Crown-4
- CAS:294-93-9
- Synonyms:1,4,7,10-Tetraoxacyclododecane
- Molecular Formula:C8H16O4
- Molecular Weight:176.21
- EINESC:206-036-5
Description
Properties
Melting point | 16 ºC |
---|---|
Water Solubility | MISCIBLE |
Boiling point | 61-70 ºC (0.5 mmHg) |
Flash point | >110 ºC |
Density | 1.089 |
Refractive index | 1.46-1.463 |
Safety
Symbol(GHS) | Xn |
---|---|
Hazard Codes | R20/21/22;R36/37/38 |
SDS/MSDS | S26;S36 |
SDS
Source | SDS/MSDS Samples |
---|---|
没有数据 | 没有数据 |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.Dan Zhang et al.Tropical medicine & international health : TM & IH, 19(10), 1259-1266 (2014-07-22)
Transport properties in aqueous ethambutol dihydrochloride.Luís M P Veríssimo et al.International journal of pharmaceutics, 479(2), 306-311 (2014-12-30)
Mycobacterium kansasii infection of the spine in a patient with sarcoidosis: a case report and literature review.Wajeeh R Bakhsh et al.Journal of surgical orthopaedic advances, 23(3), 162-165 (2014-08-26)
Multidrug-resistant tuberculosis in Western Australia, 1998-2012.Joshua R Francis et al.The Medical journal of Australia, 200(6), 328-332 (2014-04-08)
Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.Byeong-Ho Jeong et al.American journal of respiratory and critical care medicine, 191(1), 96-103 (2014-11-14)
Niosomal encapsulation of ethambutol hydrochloride for increasing its efficacy and safety.Mohammed Shafik El-Ridy et al.Drug delivery, 22(1), 21-36 (2013-12-24)
An unusual cause of breast lump: isolated tuberculosis of the breast.Partha Pal et al.The American journal of tropical medicine and hygiene, 90(5), 788-789 (2014-05-09)
Inhibition of cytochrome P450 by ethambutol in human liver microsomes.Sang Yoon Lee et al.Toxicology letters, 229(1), 33-40 (2014-06-10)
In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.N Guo et al.Letters in applied microbiology, 58(4), 344-349 (2013-12-18)
High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.Amina Jindani et al.The New England journal of medicine, 371(17), 1599-1608 (2014-10-23)
Management of paradoxical response in pediatric tubercular meningitis with methylprednisolone.Nitin Nema et al.Middle East African journal of ophthalmology, 21(2), 189-192 (2014-05-03)
Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.Hyo-Ji Kim et al.Journal of pharmaceutical and biomedical analysis, 102, 9-16 (2014-09-15)
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.S-Y Kim et al.Clinical and experimental immunology, 176(1), 93-101 (2013-12-21)
A four-month gatifloxacin-containing regimen for treating tuberculosis.Corinne S Merle et al.The New England journal of medicine, 371(17), 1588-1598 (2014-10-23)
Classical against molecular-genetic methods for susceptibility testing of antituberculotics.I Porvaznik et al.Advances in experimental medicine and biology, 835, 15-22 (2014-09-26)
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis.Stephen H Gillespie et al.The New England journal of medicine, 371(17), 1577-1587 (2014-09-10)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!